Concepedia

John Ballantyne

JB

Statistics

Publications

11

Citations

503

H-Index

11

Active since

2009

Affiliations

Aldevron (United States)(Current)

United States Army Medical Research Institute of Infectious Diseases

Sab Biotherapeutics (United States)

Maxygen (United States)

John Ballantyne is an author at Aldevron (United States) specializing in immunology, viral vaccines, and infectious diseases.

Publications per year

2009–2020

11

Publications

11

DNA vaccine–derived human IgG produced in transchromosomal bovines protect in lethal models of hantavirus pulmonary syndrome

Jay W. Hooper, Rebecca L. Brocato, Steven A. Kwilas et al. · Science Translational Medicine · 2014 · 72 citations

, , +16

A Hantavirus Pulmonary Syndrome (HPS) DNA Vaccine Delivered Using a Spring-powered Jet Injector Elicits a Potent Neutralizing Antibody Response in Rabbits and Nonhuman Primates

Steve Kwilas, Jennifer M. Kishimori, Matthew Josleyn et al. · Current Gene Therapy · 2014 · 70 citations · Full text

, , +17

A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS)

Jay W. Hooper, Matthew Josleyn, John Ballantyne et al. · Vaccine · 2013 · 66 citations · Full text

, , +17

DNA Vaccine-Generated Duck Polyclonal Antibodies as a Postexposure Prophylactic to Prevent Hantavirus Pulmonary Syndrome (HPS)

Rebecca L. Brocato, Matthew Josleyn, John Ballantyne et al. · PLoS ONE · 2012 · 54 citations · Full text

, , +17

Lipid Nanoparticle Formulation Increases Efficiency of DNA-Vectored Vaccines/Immunoprophylaxis in Animals Including Transchromosomic Bovines

Eric M. Mucker, Priya Karmali, Jerel Vega et al. · Scientific Reports · 2020 · 52 citations · Full text

, , +17

1–5 of 11